The world’s leading British pharmaceutical company, AstraZeneca PLC announced (November 27th, 2019) its official entry into Israel’s technology market through its ground breaking project the “PLAY BeyondBio”.
The investment is estimated to be about 10 million shekels. The plan is to support Israeli start-ups and provide them with access to pioneering digital health academic research. The programme will allow local start-ups to access mentoring, professional training and funding services to find technological solutions in the medical field.
Over the past few years, the convergence of healthcare and technology has become a significant growth factor in the global medical industry and the primary method for identifying and treating medical conditions.
The “PLAY BeyondBio” program is envisioned to provide ground-breaking technical solutions to the immediate challenges in the digital health field together with strategic partners from Israel National Initiative Association, Maccabitech Healthcare Research, Innovation Institute, Morris Kahn, The Sagol Fund, and Microsoft Corporation.
PLEASE READ ARTICLE HERE